Also trades as: CL.CN (CNQ) · $vol 0M
CRLBF OTC
Cresco Labs Inc.
1W: -12.9%
1M: -15.9%
3M: -15.6%
YTD: -48.4%
1Y: -53.6%
3Y: -65.4%
5Y: -93.0%
$0.65
-0.01 (-1.52%)
Weekly Expected Move ±9.4%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$230.2M
52W Range0.588-2.3
Volume215,799
Avg Volume522,764
Beta1.72
Dividend—
Analyst Ratings
Company Info
CEOCharles Bachtell
Employees2,900
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2018-12-03
Websitecrescolabs.com
600 W. Fulton Street
Chicago, IL 60661
US
Chicago, IL 60661
US
312 929 0993
About Cresco Labs Inc.
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.
Latest News
2 High-Octane Cannabis Stocks to Buy in October for Aggressive Investors
Cannabis stocks sink after DEA marijuana rescheduling hearing paused
DEA marijuana rescheduling hearing halted over GAO report
Federal court allows Trump administration marijuana rescheduling to proceed
Cannabis Stock CRLBF Surges 10% in a Month: Time to Buy or Sell?
Recent Insider Trades
No insider trades found